How long does an allogeneic stem cell transplant take to work for chronic myeloid leukaemia?

The infused donor cells must reach the marrow and start making healthy blood cells. Rising counts provide a sign of engraftment, but they do not describe every aspect of the transplant response. Your team may follow blood counts, marrow findings and the molecular marker associated with chronic myeloid leukaemia.

The donor immune system may help recognise remaining leukaemia cells, but this effect must be balanced against graft-versus-host disease. Medicines and frequent reviews are used to manage that balance. Recovery can therefore involve several milestones rather than one date when treatment suddenly starts working.

Keep every blood-test and clinic appointment, take medicines at the prescribed times and tell the team about missed doses. Follow advice about infection prevention, food safety and visitors. Protect your energy, avoid activities that could cause injury while counts are low, and keep records of symptoms, temperature and questions for review.

Contact the transplant team urgently for fever, chills, new breathlessness, bleeding, severe diarrhoea, vomiting, a spreading rash, yellow skin, reduced urine or confusion. These symptoms can reflect infection, graft-versus-host disease or another transplant problem. Use emergency services for severe breathing trouble, heavy bleeding or collapse.

Ask which result will confirm engraftment, how your chronic myeloid leukaemia molecular marker will be followed, and when marrow or blood testing is planned. Ask how medicines will be adjusted, which symptoms could indicate graft-versus-host disease, and whom to contact overnight or at weekends.